We reasoned that VEGFR-2+/CD31+ endothelial cells might play a more important role at the very early stages of tumor growth, when such cells appear in response to activation of a pro-angiogenic program in tumor cells, the so-called angiogenic switch [2]. The gene discussed is PECAM1; the disease is neoplasm.